Hannover Re : The support should not be expected to rein in the decline
SELL
Conditionne
Target price hit
Entry price | Target | Stop-loss | Potential |
---|
€103.5 |
€98 |
€105 |
+5.31% |
---|
The breach of the technical support level that is currently being tested, should be anticipated with a probable further acceleration up ahead.
Summary● The company usually posts poor financials for mid or long term investments.
Strengths● The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at EUR 103.2 EUR in weekly data.
● Share prices are approaching a strong support area in daily data, which offers good timing for investors.
● The group usually releases upbeat results with huge surprise rates.
● Its low valuation, with P/E ratio at 11.75 and 11.55 for the ongoing fiscal year and 2018 respectively, makes the stock pretty attractive with regard to earnings multiples.
● The company is one of the best yield companies with high dividend expectations.
● The tendency within the weekly time frame is positive above the technical support level at 103.2 EUR
Weaknesses● As estimated by analysts, this group is among those businesses with the lowest growth prospects.
● Revenue estimates are regularly revised downwards for the current and coming years.
● For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.